2,470 new COVID-19 cases reported on Nov 1 – 863 aged between 12 and 39

​​There were 2,470 new COVID-19 cases in Singapore on Monday (Nov 1), said the Ministry of Health (MOH).

Among the new cases, 2,189 infections were from the community and 863 of those infected were aged between 12 and 39. 

The cluster at Orange Valley Nursing Home in Clementi has reported another three new cases, bringing the total to 17 cases.

MOH is closely monitoring five other active clusters that have reported new cases. These include the Institute of Mental Health, Bukit Batok Home for the Aged, Banyan Home @ Pelangi Village, Acacia Home and Jamiyah Home for the Aged in Tampines. These five clusters have reported 36 new cases in total.

There were 14 COVID-19-related deaths reported on Nov 1, aged between 56 and 95 years old. All of them had underlying medical conditions, except one unvaccinated individual. This brings the national death toll to 421.

3,552 cases were discharged from hospitals on Nov 1. Currently, 1,717 cases are warded, with 288 cases requiring oxygen supplementation in general wards. There are 129 cases in the Intensive Care Unit.

Singapore has recorded 94,376 cases in the last 28 days, of which 98.7 per cent had no or mild symptoms, and 0.8 per cent have required oxygen supplementation.

84 per cent of the population are fully vaccinated, while 85 per cent received at least one dose of the vaccine, and 16 per cent have received boosters.

From Nov 1, individuals aged 30 and above will also be able to walk in to any of the Moderna Vaccination Centres to take their booster dose, making it more convenient to get booster shots quickly. This applies to all Singaporeans, Permanent Residents, and Long-Term Pass Holders aged 30 years and above who have completed their second dose six months ago.

Individuals can now also make appointments to take the Sinovac-CoronaVac COVID-19 vaccine at Raffles City Convention Centre. Due to the lower efficacy of the vaccine, people are still strongly encouraged to complete a two-dose primary regime with the mRNA vaccines as they offer more protection. Previously, the Sinovac-CoronaVac vaccine was only offered at selected authorised private clinics.